It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1995.
1995 | Hyderabad, Telangana, India | Converted to LLPSaketha Drugs And Intermediates Limited, a converted to llp public limited company, was established on 08 June 1995 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239TG1995PLC020625. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1,840.00 Cr and a paid-up capital of ₹1,828.95 Cr.
Past directors included Bandi Vamsikrishna, Chandra Sekhar Tumuluru, Parthasaradhi Reddy Bandi. Its latest AGM occurred on 26 May 2016, with the balance sheet filed on 31 March 2016. It is based at H.No.8-3-166/7/1,Third Floor, Hetero House,Erragadda, Hyderabad, Telangana, 500018.
U24239TG1995PLC020625
020625
08 June 1995
₹1,840.00 Cr
₹1,828.95 Cr
Roc Hyderabad
Unlisted
Converted to LLP
Explore comprehensive insights into Saketha Drugs And Intermediates Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Jun 2011 | Past |
| Pramod Abcsdd | Director | 19 Jan 2017 | Past |
| Pramod Abcsdd | Director | 31 Mar 2015 | Past |
| Pramod Abcsdd | Director | 29 Jun 2011 | Past |
| Pramod Abcsdd | Director | 19 Jan 2017 | Past |
| Pramod Abcsdd | Director | 19 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Saketha Drugs And Intermediates Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 63.73% increase in profit. The company's net worth dipped by a decrease of 0.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Saketha Drugs And Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Saketha Drugs And Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Saketha Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saketha Drugs And Intermediates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Saketha Drugs And Intermediates Limited last Annual general meeting of members was held on 26 May 2016 as per latest MCA records. was completed.
The activity Saketha Drugs And Intermediates Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Hyderabad. was completed.
The activity Saketha Drugs And Intermediates Limited was registered on 08 Jun 1995 with Roc Hyderabad & aged 30 years 7 months as per MCA records. was completed.
The CIN of Saketha Drugs And Intermediates Limited is U24239TG1995PLC020625.
Saketha Drugs And Intermediates Limited is headquartered at H.No.8-3-166/7/1,Third Floor, Hetero House,Erragadda, Hyderabad, Telangana, 500018.
Saketha Drugs And Intermediates Limited was incorporated on 08 June 1995.
The primary industry of Saketha Drugs And Intermediates Limited is Pharma.
Saketha Drugs And Intermediates Limited is unlisted.
The authorized capital of Saketha Drugs And Intermediates Limited is ₹1,840.00 Cr, and the paid-up capital is ₹1,828.95 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX